All transfers of value to HCPs and HCOs have been collected since 2015 being reported the year after it occurs. This includes,
- Grants and donations to HCOs
- Speaker and consultancy fees for HCPs
- Sponsoring of events organized by or on behalf of HCOs
- Invitation of HCPs to congresses and educational or scientific Meetings
- Research and development related transfers of value (only as aggregated Report)
The proposed EFPIA format for the disclosure report is used by the local pharma associations in Europe which are direct members of EFPIA. The report defines the different categories and how to disclose transfer of values to HCPs and HCOs on an annual basis.
Transfers of value done to HCPs and HCOs during 2016 are published together with a methodological note how Grünenthal is collecting and disclosing the data in the reports. Transfers of values to HCPs and HCOs are published by the Grünenthal affiliate of the country of the recipient and will include also transfers of values which are made by any other affiliate from Grünenthal.
Depending on the country regulations the information will be either published on the website of the respective Grünenthal affiliate or in a public registry which is being made available by the respective countries.
The complete overview of the transfers of values for the whole Group can be found below and is accessible via the short link: http://www.transparency.grunenthal.com
Data Protection Notice
“Grünenthal is committed to handling personal data in a manner that is both responsible and compliant with applicable law. In that regard, we have obtained the consent of the HCPs and HCOs to publish their personal data on our websites for transparency purposes in accordance with EFPIA standards. However, the consent we have obtained is limited to the particular purpose of publication on our websites and the use of this information for any other purpose is prohibited since it would infringe the data protection rights of the HCPs and HCOs.
For a good understanding of the reporting included in our disclosures, as published on this website, we refer to the Methodological Note that clarifies the meaning and content of the transfers of value reported.”